University of Tennessee Research Foundation:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:University of Tennessee Research Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9346
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of Tennessee Research Foundation (UTRF) is a non profit organization that promotes commercialization of UT intellectual property and encourages an entrepreneurial culture and contributes to state and regional economic development, and promotes research and education. The organization offers chemistry and materials, agriculture, engineering, energy, animal health, human health, research tools and software and copyright technologies. It supports research programs of University of Tennessee in the areas of chemistry, pharmaceuticals, biology, and alternative energy. UTRF commercializes and assist in the marketing, evaluation, and licensing of technology developed at the university. The organization serves researchers, entrepreneurs, industries, and investors of agriculture, animal health, chemistry and materials and other industries. UTRF is headquartered in Knoxville, Tennessee, the US.

University of Tennessee Research Foundation – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of Tennessee Research Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of Tennessee Research Foundation, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
University of Tennessee Research Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of Tennessee Research Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
University of Tennessee Research Foundation, Medical Devices Deals, 2012 to YTD 2018 9
University of Tennessee Research Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
University of Tennessee Research Foundation, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Meridian Bioscience Enters into Licensing Agreement with University of Tennessee for Electrokinetic Sensor Technology 11
Licensing Agreements 12
CytoSen Therapeutics Enters into Licensing Agreement with University of Tennessee Research Foundation 12
GTx Enters into Licensing Agreement with University of Tennessee Research Foundation 13
University of Tennessee Research Foundation – Key Competitors 15
University of Tennessee Research Foundation – Key Employees 16
University of Tennessee Research Foundation – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
University of Tennessee Research Foundation, Pharmaceuticals & Healthcare, Key Facts 2
University of Tennessee Research Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of Tennessee Research Foundation, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
University of Tennessee Research Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of Tennessee Research Foundation, Deals By Therapy Area, 2012 to YTD 2018 8
University of Tennessee Research Foundation, Medical Devices Deals, 2012 to YTD 2018 9
University of Tennessee Research Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Meridian Bioscience Enters into Licensing Agreement with University of Tennessee for Electrokinetic Sensor Technology 11
CytoSen Therapeutics Enters into Licensing Agreement with University of Tennessee Research Foundation 12
GTx Enters into Licensing Agreement with University of Tennessee Research Foundation 13
University of Tennessee Research Foundation, Key Competitors 15
University of Tennessee Research Foundation, Key Employees 16
University of Tennessee Research Foundation, Other Locations 17

List of Figures
University of Tennessee Research Foundation, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
University of Tennessee Research Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
University of Tennessee Research Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
University of Tennessee Research Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
University of Tennessee Research Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of Tennessee Research Foundation, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
University of Tennessee Research Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of Tennessee Research Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
University of Tennessee Research Foundation, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[University of Tennessee Research Foundation:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ascena Retail Group, Inc.:企業の戦略・SWOT・財務分析
    Ascena Retail Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Ascena Retail Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • PGNiG SA (PGN):石油・ガス:M&Aディール及び事業提携情報
    Summary PGNiG SA (PGNiG) is a vertically integrated gas company. The company’s activities include domestic natural gas and crude oil production, development of natural gas and crude oil fields in Poland and abroad, provision of geological, geophysical and exploration services in Poland and abroad, i …
  • Intrexon Corp (XON)-製薬・医療分野:企業M&A・提携分析
    Summary Intrexon Corp (Intrexon), formerly Genomatix Corp is a provider of therapeutic solutions. The company operates through its divisions such as human therapeutics, protein production, industrial products, agricultural biotech, and animal sciences. Its human therapeutics division develops therap …
  • Medshape Inc-医療機器分野:企業M&A・提携分析
    Summary Medshape Inc (MedShape), formerly MedShape Solutions Inc is a medical device company that develops and manufactures orthopedic devices for the orthopedic healthcare markets. The company’s products include dynanail ankle arthrodesis nail, eclipse soft tissue anchor, exoshape teno soft tissue …
  • Taihan Electric Wire Co Ltd (001440):企業の財務・戦略的SWOT分析
    Taihan Electric Wire Co Ltd (001440) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Gilead Sciences Inc (GILD)-医療機器分野:企業M&A・提携分析
    Summary Gilead Sciences Inc (Gilead) is a research-based biopharmaceutical company. It focuses on the discovery, development and commercialization of medicines for the treatment of cardiovascular and respiratory diseases, inflammation, liver diseases, cancer and human immunodeficiency virus (HIV) in …
  • Gemphire Therapeutics Inc (GEMP):企業の財務・戦略的SWOT分析
    Gemphire Therapeutics Inc (GEMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Bollore SA (BOL):企業の財務・戦略的SWOT分析
    Bollore SA (BOL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • General Electric Co (GE)-医療機器分野:企業M&A・提携分析
    Summary General Electric Company (GE) is a digital industrial company. It offers a range of industrial, infrastructure and financial services globally. The company offers a range of products and services from aircraft engines, power generation and oil and gas production equipment to medical imaging, …
  • Sebia SA:医療機器:M&Aディール及び事業提携情報
    Summary Sebia SA (Sebia) is a medical device company that designs, manufactures, commercializes, and exports electrophoresis tests and analyzers. The company's electrophoresis program offers automated system for capillary electrophoresis, gel electrophoresis and electrophoresis scanning software. It …
  • ContextVision AB (COV):企業の財務・戦略的SWOT分析
    Summary ContextVision AB (ContextVision) is a medical technology company that specializes in image analysis and artificial intelligence software solutions. The company develops image enhancement software solutions for magnetic resonance imaging, digital pathology, ultrasound, X-ray, fluoroscopy, mam …
  • CBS Corporation (CBS):企業の財務・戦略的SWOT分析
    CBS Corporation (CBS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Thetis Pharmaceuticals LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Thetis Pharmaceuticals LLC (Thetis Pharma) is a drug manufacturing company that offers novel immuno-resolving therapies. The company develops and manufactures drugs for type two diabetes and chronic conditions. Its pipeline products include TP252, TP6211, TP113, and TP 101. Thetis Pharma’s T …
  • Mundipharma International Ltd:企業の戦略的SWOT分析
    Mundipharma International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Molinos Rio de la Plata SA (MOLI3):企業の財務・戦略的SWOT分析
    Molinos Rio de la Plata SA (MOLI3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Karnataka Power Corporation Ltd-エネルギー分野:企業M&A・提携分析
    Summary Karnataka Power Corporation Limited (KPCL) is a state owned power generating company in Karnataka. It is responsible for development and operation of power plants including hydro, thermal, solar and wind. KPCL supplies power to state owned power distribution companies based on power purchase …
  • VisionCare Inc-医療機器分野:企業M&A・提携分析
    Summary VisionCare Inc (VisionCare) is a medical device company that researches, develops, manufactures, and markets proprietary implantable ophthalmic devices and technologies for the treatment of retinal disorders. The company offers implantable miniature telescope, an implantable medical device t …
  • Wns (Holdings) Limited:企業の戦略・SWOT・財務分析
    Wns (Holdings) Limited - Strategy, SWOT and Corporate Finance Report Summary Wns (Holdings) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • MallInckrodt Plc (MNK):医療機器:M&Aディール及び事業提携情報
    Summary Mallinckrodt Plc (Mallinckrodt) is develops, produces, commercializes, and distributes specialty pharmaceutical therapies and products. The company offers both branded and specialty generics for autoimmune and rare diseases in the specialty therapeutic areas of rheumatology, nephrology, neur …
  • Storm Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Storm Therapeutics Ltd (Storm Therapeutics) a spin-out of University of Cambridge is focused on developing small molecule inhibitors of RNA-modifying enzymes for the treatment of cancer and other diseases. The company is engaged in modulating RNA modifying enzymes and is developing a unique …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆